MARKET

RVMD

RVMD

Revolution Medicines, Inc.
NASDAQ
209.46
-2.28
-1.07%
After Hours: 209.50 +0.04 +0.02% 19:50 08/21 EDT
OPEN
212.06
PREV CLOSE
211.74
HIGH
212.74
LOW
206.75
VOLUME
2.12M
TURNOVER
--
52 WEEK HIGH
220.34
52 WEEK LOW
35.42
MARKET CAP
44.89B
P/E (TTM)
-23.7085
1D
5D
1M
3M
1Y
5Y
1D
Revolution Medicines’ Earnings Call: Pivotal Data, Rising Spend
TipRanks · 15h ago
Revolution Medicines Is Maintained at Market Perform by Bernstein
Dow Jones · 1d ago
Bernstein Maintains Market Perform on Revolution Medicines, Raises Price Target to $179
Benzinga · 1d ago
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), Revolution Medicines (RVMD) and MDxHealth (MDXH)
TipRanks · 1d ago
Revolution Medicines price target raised to $179 from $151 at Bernstein
TipRanks · 1d ago
Revolution Medicines Advances RASolve 308 Lung Cancer Trial, Raising Long-Term Upside Potential for RVMD
TipRanks · 1d ago
Incyte ‘734 update likely to be ‘very competitive,’ says RBC Capital
TipRanks · 3d ago
Revolution Medicines (RVMD) Is Up 5.1% After Offloading Phase 3 Costs to BeOne Medicines
Simply Wall St · 3d ago
More
About RVMD
Revolution Medicines, Inc. is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The Company's research and development pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The Company is advancing a pipeline of RAS(ON) Inhibitors, daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor are in clinical development. The Company's pipeline also focus on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C). The Daraxonrasib, our RAS(ON) multi-selective inhibitor, is designed as an oral, tri-complex inhibitor of multiple RAS(ON) variants containing cancer driver mutations at all three of the major RAS mutation hotspot positions, G12, G13, and Q61.

Webull offers Revolution Medicines Inc stock information, including NASDAQ: RVMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVMD stock methods without spending real money on the virtual paper trading platform.